Anti-ARID1B antibody (ab57461)

ab57461 has been referenced in 6 publications.

• Wang B  et al. Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma. J Cancer 8:3490-3497 (2017). PubMed: 29151933
• Shibutani M  et al. Arid1b Haploinsufficiency Causes Abnormal Brain Gene Expression and Autism-Related Behaviors in Mice. Int J Mol Sci 18:N/A (2017). PubMed: 28867767
• Kelso TWR  et al. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. Elife 6:N/A (2017). PubMed: 28967863
• Gurard-Levin ZA  et al. Chromatin Regulators as a Guide for Cancer Treatment Choice. Mol Cancer Ther 15:1768-77 (2016). PubMed: 27196757
• Raab JR  et al. Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. PLoS Genet 11:e1005748 (2015). PubMed: 26716708
• Helming KC  et al. ARID1B is a specific vulnerability in ARID1A-mutant cancers. Nat Med 20:251-4 (2014). WB ; Human . PubMed: 24562383